DUBLIN, Jan. 4, 2022 /PRNewswire/ — The "Healthcare Artificial Intelligence (AI) Market – Global Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The healthcare artificial intelligence market is expected to reach USD 44.5 billion by 2026, growing at a CAGR of 46.21%.
Several pharmaceutical companies are implementing innovative technologies to boost their growth in the global healthcare industry. Collaboration of GSK with Exscientia identified a small compound for targeted therapeutics and its characteristics towards the specific target using the AI platform. AI is becoming an incredible platform in the pharmaceutical industry.
For instance, Novartis announced Microsoft as a strategic partner in AI and data science to set up an AI innovation lab. Since the last year, over 50+ companies have got machine learning and AI algorithms approvals. During the COVID-19 pandemic, AI played a significant role in the healthcare industry. An analytics study by Accenture combined with clinical applications demonstrated the potential of AI to reduce approximately USD 150 billion per annum by 2026 in the US healthcare system.
The following factors are likely to contribute to the growth of the healthcare artificial intelligence market during the forecast period:
Increase in patient volume & complexities associated with data fueling demand for AI.
The shrinking operational workforce in healthcare facilities propelling the need for AI.
Technological advancement & innovations in AI influencing end-users in the market.
Rising Investment in advanced drug discovery & development process augmenting the adoption of AI.
Key Highlights
The healthcare providers segment accounted for the largest market share with around 48% compared to others in 2020.
According to the research, the publisher estimated that APAC would witness the highest growth in the healthcare artificial intelligence (AI) market during the forecast period.
The study considers a detailed scenario of the present healthcare artificial intelligence market and its market dynamics for the period 2021?2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Vendor Analysis
Giant players are focusing on pursuing organic growth strategies to enhance their product portfolio in the healthcare artificial intelligence (AI) market. Several initiatives by the players will complement growth strategies, which are gaining traction among end-users in the market. Rising growth of startups collaborating with key vendors in promoting their artificial intelligence in healthcare applications creating heavy competition in the market.
Key Questions Answered:
1. How big is the healthcare artificial intelligence (AI) market?
2. Which region has the highest share in the healthcare artificial intelligence market?
3. Who are the key players in the healthcare AI market?
4. What are the latest market trends in the healthcare artificial intelligence market?
5. What is the use of AI in the healthcare market?
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation By Component
4.3.2 Market Segmentation By Application
4.3.3 Market Segmentation By Technology
4.3.4 Market Segmentation By End-User
4.3.5 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market At A Glance
7 Introduction
7.1 Healthcare Artificial Intelligence (AI)
8 Market Opportunities & Trends
8.1 Rising Investments In Advanced Drug Discovery & Development Processes
8.2 Mergers, Acquisitions, & Collaborations With Life Science & Medical Device Companies
8.3 Influx/Emergence Of Many Startups In The Healthcare AI Industry
9 Market Growth Enablers
9.1 Increase In Patient Volume & Complexities Associated With Data
9.2 Shrinking Operational Workforce In Healthcare Facilities
9.3 Technological Advancements & Innovations In AI
9.4 Growing Need To Reduce Healthcare Costs Using It & AI Technologies
10 Market Restraints
10.1 High Installation & Implementation Cost Of AI & Related Platforms
10.2 Lack Of Skilled AI Workforce & Resistance Among Healthcare Professionals
10.3 Stringent & Ambiguous Regulations For Healthcare Software & AI Technologies
10.4 Absence Of Interoperability Among Commercially Available Ai Solutions Coupled With Data Privacy Issues
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry
12 Component
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hardware
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Hardware: Geography Segmentation
12.4 Software & Services
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Software & Services: Geography Segmentation
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospital Workflow Management
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Hospital Workflow Management: Geography Segmentation
13.4 Medical Imaging & Diagnosis
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Medical Imaging & Diagnosis: Geography Segmentation
13.5 Drug Discovery & Precision Medicine
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Drug Discovery & Precision Medicine: Geography Segmentation
13.6 Patient Management
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Patient Management: Geography Segmentation
14 Technology
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Machine Learning
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Machine Learning: Geography
14.4 Querying Method
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Querying Method: Geography Segmentation
14.5 Natural Language Processing
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Natural Language Processing: Geography Segmentation
14.6 Other Technology
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Other Technology: Geography Segmentation
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Healthcare Providers
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Healthcare Providers: Geography Segmentation
15.4 Pharma-Biotech & Medical Device Companies
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Pharma-Biotech & Medical Device Companies: Geography Segmentation
15.5 Payers
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Payers: Geography Segmentation
15.6 Others
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.6.3 Other End User: Market By Geography
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
18 Europe
19 APAC
20 Latin America
21 Middle East & Africa
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Google
22.2.2 IBM
22.2.3 Intel
22.2.4 Medtronic
22.2.5 Microsoft
22.2.6 NVIDIA
22.2.7 Siemens Healthineers
23 Key Company Profiles
23.1 GOOGLE
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 INTERNATIONAL BUSINESS MACHINES (IBM)
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 INTEL CORPORATION
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 MEDTRONIC
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 MICROSOFT CORPORATION
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 NVIDIA CORPORATION
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 SIEMENS HEALTHINEERS
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
24 Other Prominent Vendors
24.1 ARTERYS
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 CAPTION HEALTH
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 ENLITIC
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 CATALIA HEALTH
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 GENERAL VISION
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 PHILIPS
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 STRYKER
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 SHIMADZU RECURSION PHARMACEUTICALS
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 GE HEALTHCARE
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 REMEDY MEDICAL
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 SUBTLE MEDICAL
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 NETBASE QUID
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 BIOSYMETRICS
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 SENSELY
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 INFORMAI
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 BIOCLINICA
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 OWKIN
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 BINAH.AI
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 ONCORA MEDICAL
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 QURE.AI TECHNOLOGIES
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 LUNIT
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 CARESYNTAX
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 ANJU SOFTWARE
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 IMAGIA CYBERNETICS
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 DEEP GENOMICS
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 WELLTOK INC.
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 MDLIVE
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 MAXQ AI
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 QVENTUS
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 WORKFUSION
24.30.1 Business Overview
24.30.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
27 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/96c7c
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/the-worldwide-healthcare-artificial-intelligence-industry-is-expected-to-reach-44-5-billion-by-2026–301453532.html
SOURCE Research and Markets
Yahoo Finance's Jared Blikre reports on the market as stocks tumble after the release of the Federal Open Market Committee's meeting.
This year could be a big one for Novavax (NASDAQ: NVAX). The biotech company fell behind in the coronavirus vaccine race last year. Novavax just completed its data submission to the U.S. Food and Drug Administration (FDA).
Rivian shares are down 6% in early trading Wednesday. News regarding Amazon.com, a Rivian customer and investor, has other Rivian investors vexed.
Yahoo Finance's Akiko Fujita breaks down why software company stocks like Adobe and Salesforce are declining today.
Technology stocks came under renewed pressure on Wednesday while the Dow set a fresh record high, with investors turning away from tech. and growth stocks in anticipation of higher rates.
Data analytics stock Palantir Technologies (NYSE: PLTR) dropped 11.8% in December as investors continue to move away from growth stocks with high valuations. Similar stocks, including Splunk (NASDAQ: SPLK) and Alteryx (NYSE: AYX), had very similar charts throughout the month. This indicates that market forces are behind the move, which occurred without any significant news from Palantir.
Yahoo Finance’s Ines Ferre breaks down how Microsoft is heading for its longest losing streak since September, Sony's new operating company Sony Mobility is entering the EV space, and how Wayfair continues to sink to a 52-week low.
DoubleLine Capital Founder and CEO Jeffrey Gundlach sits down with Yahoo Finance Live's Brian Sozzi to discuss the probability of a recession in 2023, the Fed, car prices, stock overvaluation, the S&P 500, and China.
Tilray (NASDAQ: TLRY) shareholders lost ground to the market in December, with the stock slumping 31% compared to a 4% spike in the S&P 500, according to data provided by S&P Global Market Intelligence. Tilray shares had been up more than 200% in early 2021 but finished the year in negative territory compared to a 27% surge in the wider stock market. December brought two important updates on the pot stock's business.
Leading meme stocks were taking investors down more than a notch or two Tuesday as AMC Entertainment Holdings (NYSE: AMC) and GameStop (NYSE: GME) were falling by 5.6% and 4.6%, respectively, heading into noontime trading. On the other hand, Sundial Growers (NASDAQ: SNDL), after falling more than 2% to start the day, began rallying and managed to break through into positive territory. It's an inauspicious start to the new year for movie theater operator AMC, which lost 2.5% of its value yesterday and has lost nearly 10% over the past month, while GameStop is down even more, falling 15% since early December.
H&R Real Estate Investment Trust ("H&R") (TSX: HR.UN) and Primaris Real Estate Investment Trust ("Primaris") (TSX: PMZ.UN) jointly announced today that the internal reorganization of H&R pursuant to which H&R's enclosed shopping mall business and certain other assets were spun-out to Primaris was completed on December 31, 2021. The transaction was implemented by way of a statutory plan of arrangement (the "Arrangement") and H&R unitholders received one unit of Primaris for every four units of H&
Shares of e-commerce and logistics company ContextLogic (NASDAQ: WISH), commonly called Wish, plunged 16.6% in December, according to data provided by S&P Global Market Intelligence. The tough times for Wish started on Dec. 2 when Kunal Madhukar, an analyst with UBS, downgraded the stock from buy to neutral, according to The Fly. To summarize, Madhukar believes revenue will be challenged in 2022 and expenses will remain high.
U.S. share benchmarks fell as investors analyzed minutes from the Federal Reserve’s recent policy meeting in hopes of new clues about weaning markets off stimulus measures.
Shares of cloud computing software giant salesforce.com (NYSE: CRM) were down 6.4% Wednesday as of 12:55 p.m. ET. Salesforce is now down 18% from its all-time high reached in November 2021. There was no specific news from Salesforce that caused this most recent dip.
Peter Saleh, BTIG Managing Director, joins Yahoo Finance Live to talk about KFC's partnership with Beyond Meat on plant-based chicken and the push to have plant-based foods in 2022.
Nikola (NASDAQ: NKLA) announced its first commercial shipments last month, and more related news today had the stock of the zero-emissions truck maker soaring by double digits early Wednesday. After popping as much as 11.5% this morning, as of 10:56 a.m. ET, Nikola shares are trading 6.3% higher. Two items of note have investors pushing up shares in Nikola today.
The key to investment success in 2022 is likely to be diversity; that is, a broad range of portfolio allocations that spread investment money across multiple sectors. In short, don’t put all of your eggs into one basket. Last year saw tremendous gains – some 29% on the S&P 500 – fueled by better-than-expected earnings. The rebound from the short, sharp 2020 COVID recession was real, but may have also given investors a distorted picture of the markets. For starters, the supply chain disruptions o
The majority of Berkshire Hathaway’s holdings are now dividend stocks.
Electric truck start-up Rivian (NASDAQ: RIVN) enjoyed an explosive initial public offering (IPO) late last year, more than doubling its price in its first week as a public company. Sadly, Rivian stock is moving in the opposite direction today. In a note out last night, investment bank Mizuho Securities argued that Rivian stock was a buy even before this morning's sell-off.
In this article, we discuss the top 10 stocks to buy according to billionaire Steve Cohen. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stocks to Buy According to Billionaire Steve Cohen. Steve Cohen is the founder, president, and chief executive officer of Point72 Asset Management, […]
